Standards That Build Trust. Systems That Support Partnership.
Bio International Pharma Ltd.
At Bio International Pharma Ltd., quality and regulatory compliance are embedded within daily operations rather than treated as administrative functions. Structured procedures govern product receipt, storage, handling, dispatch, documentation, and recall readiness — reinforcing product integrity across the distribution cycle.
Operational controls are designed not only to meet regulatory requirements, but to provide manufacturing partners with confidence in in-market execution.
Bio International Pharma Ltd. operates under the regulatory authority of the Supreme Medical and Pharmaceutical Authority (SBDMA) of the Republic of Yemen.
The company holds:
• Pharmaceutical import license
• Wholesale distribution license
• Product-specific marketing authorizations for registered products
Internal procedures align with WHO Good Distribution Practice (GDP) guidelines, supporting structured documentation, controlled storage, and traceable distribution processes.
Quality management is implemented through documented Standard Operating Procedures covering:
• Receiving and inspection processes
• Batch verification and documentation review
• Temperature monitoring and storage validation
• Picking, packing, and dispatch controls
• Returns and recall management
• Customer complaint handling and root cause analysis
Inventory is managed under First-Expiry, First-Out (FEFO) principles to minimize expiry risk and ensure product freshness.
Cold chain documentation is maintained at each transfer stage, with defined protocols for excursion identification, reporting, and corrective action.
Bio International Pharma Ltd. maintains structured processes supporting pharmacovigilance coordination with manufacturing partners.
Field representatives are trained to identify and escalate suspected adverse drug reactions in accordance with regulatory requirements. Batch-level distribution records enable full traceability from international receipt through specific customer delivery — supporting recall execution and regulatory reporting where necessary.
The company operates under formal quality and distribution agreements with international manufacturing partners, defining mutual expectations for:
• Product handling standards
• Temperature control requirements
• Documentation and reporting
• Issue resolution and corrective actions
Bio International Pharma Ltd. welcomes partner audits as opportunities to validate operational standards and reinforce long-term collaboration.
Quality management is viewed as a shared responsibility between distributor and manufacturer — forming the foundation of sustainable partnership.
